Immuneering Corporation

IMRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.55

+$0.11 (+2.48%)

Sep 22, 2026, 12:09 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-56.02M	-61.04M	-53.47M	-50.51M	-33.54M	-17.04M
Depreciation & Amortization	698.89K	385.07K	352.08K	796.79K	159.07K	79.31K
Stock-Based Compensation	n/a	6.5M	5.73M	n/a	1.8M	1.09M
Other Working Capital	4.22M	-813.24K	119.84K	-276.56K	751.1K	357.58K
Other Non-Cash Items	6.16M	75.98K	-601.59K	3.9M	130.24K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	-307.49K	n/a
Change in Working Capital	3.82M	-925.38K	-974.64K	1.72M	900.42K	1.25M
Operating Cash Flow	-45.34M	-55M	-48.97M	-44.1M	-30.85M	-14.62M
Capital Expenditures	-142.23K	-84.88K	-342.75K	-742.49K	-60.79K	-53.42K
Cash Acquisitions	n/a	n/a	n/a	n/a	70.35K	n/a
Purchase of Investments	-88.6M	-5.41M	-44.66M	-50.1M	-75.63M	n/a
Sales Maturities Of Investments	n/a	31.93M	52.3M	92.68M	75.62M	n/a
Other Investing Acitivies	247	n/a	n/a	n/a	-75.62M	n/a
Investing Cash Flow	-88.74M	26.43M	7.3M	41.83M	-75.62M	-53.42K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-147	1.07M	241.07K	n/a	-842.76K	n/a
Financial Cash Flow	226.58M	5.3M	28.44M	19K	144.26M	37.98M
Net Cash Flow	92.5M	-23.26M	-13.23M	-2.25M	37.8M	23.31M
Free Cash Flow	-45.49M	-55.08M	-49.31M	-44.84M	-30.91M	-14.67M
Adj. Free Cash Flow	-45.49M	-61.59M	-55.04M	-44.84M	-32.71M	-15.76M
Maintenance CapEx	-142.23K	-84.88K	-342.75K	-742.49K	-60.79K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	-53.42K
Owner Earnings	-45.49M	-55.08M	-49.31M	-44.84M	-30.91M	-14.62M